5/3/24 16:29 | 5/2/24 | ARQT | Health | Drug | Pharmaceutical Preparations | Moore Matthew Richard | CA | O | SVP,Chie | S | -41 | 8.74 | 0 | -5 | -3 | 146 | D | | | | | | | | | | | | | | |
5/3/24 16:22 | 5/2/24 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S | -120 | 8.74 | 0 | -14 | -1 | 1,092 | D | | | | | | | | | | | | | | |
5/3/24 16:22 | 5/2/24 | ARQT | Health | Drug | Pharmaceutical Preparations | Matsuda Masaru | CA | O | See Rema | S | -44 | 8.74 | 0 | -5 | -3 | 185 | D | | | | | | | | | | | | | | |
5/3/24 16:22 | 5/2/24 | ARQT | Health | Drug | Pharmaceutical Preparations | Burnett Patrick | CA | O | See Rema | S | -83 | 8.74 | 0 | -10 | -4 | 260 | D | | | | | | | | | | | | | | |
3/6/24 17:14 | 3/4/24 | ARQT | Health | Drug | Pharmaceutical Preparations | Matsuda Masaru | CA | O | See Rema | S | -42 | 11.12 | 0 | -4 | -2 | 190 | D | | | | | | | | | | | | | | |
3/6/24 17:12 | 3/4/24 | ARQT | Health | Drug | Pharmaceutical Preparations | Burnett Patrick | CA | O | See Rema | S | -53 | 11.12 | 0 | -5 | -2 | 269 | D | | | | | | | | | | | | | | |
3/6/24 17:09 | 3/4/24 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S | -166 | 11.12 | 0 | -15 | -1 | 1,106 | D | | | | | | | | | | | | | | |
3/6/24 17:08 | 3/4/24 | ARQT | Health | Drug | Pharmaceutical Preparations | Moore Matthew Richard | CA | O | SVP,Chie | S | -39 | 11.12 | 0 | -3 | -2 | 146 | D | | | | | | | | | | | | | | |
3/6/24 16:28 | 3/4/24 | ARQT | Health | Drug | Pharmaceutical Preparations | Heron Patrick J | CA | D | | P | 200 | 9.50 | 0 | 21 | 0 | 8,818 | I | | | | | | | | | | | | | | |
3/1/24 16:11 | 2/28/24 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S | -26 | 10.60 | 0 | -2 | 0 | 1,121 | D | | | | | | | | | | | | | | |
1/3/24 17:30 | 1/2/24 | ARQT | Health | Drug | Pharmaceutical Preparations | Burnett Patrick | CA | O | See Rema | S | -5 | 3.54 | 0 | -1 | -2 | 57 | D | | | | | | | | | | | | | | |
12/1/23 20:51 | 12/1/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | M.d | 100 | 1.68 | 0 | 60 | 9 | 733 | D | | | | | | | | | | | | | | |
12/1/23 20:51 | 5/31/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | P.d | 9 | 6.38 | 0 | 1 | 0 | 733 | D | | | | | | | | | | | | | | |
11/21/23 17:47 | 11/21/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Matsuda Masaru | CA | O | See Rema | S | -4 | 1.98 | 0 | -2 | -4 | 47 | D | | | | | | | | | | | | | | |
10/26/23 16:09 | 10/24/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Frazier Life Sciences Viii, L.P. | CA | T | | P | 200 | 2.50 | 0 | 80 | 1 | 8,827 | D | | | | | | | | | | | | | | |
8/22/23 12:24 | 8/21/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Burnett Patrick | CA | O | See Rema | S | -11 | 7.04 | 0 | -2 | -3 | 58 | D | | | | | | | | | | | | | | |
6/2/23 20:31 | 5/31/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Matsuda Masaru | CA | O | See Rema | S | -14 | 7.80 | 0 | -2 | -4 | 44 | D | | | | | | | | | | | | | | |
4/18/23 19:00 | 4/17/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 14 | 1.68 | 0 | 9 | 5 | 191 | D | | | | | | | | | | | | | | |
4/18/23 19:00 | 4/17/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | S.d | -119 | 13.97 | 0 | -9 | -4 | 191 | D | | | | | | | | | | | | | | |
4/10/23 16:13 | 4/6/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 14 | 1.68 | 0 | 9 | 5 | 191 | D | | | | | | | | | | | | | | |
4/10/23 16:13 | 4/6/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | S.d | -102 | 12.01 | 0 | -9 | -4 | 191 | D | | | | | | | | | | | | | | |
3/8/23 16:29 | 3/6/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S | -37 | 15.26 | 0 | -2 | 0 | 585 | D | | | | | | | | | | | | | | |
3/8/23 16:29 | 3/6/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | CA | O | CFO | S | -4 | 15.26 | 0 | 0 | 0 | 59 | D | | | | | | | | | | | | | | |
3/8/23 16:28 | 3/6/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Burnett Patrick | CA | O | See Rema | S | -13 | 15.26 | 0 | -1 | -1 | 60 | D | | | | | | | | | | | | | | |
3/8/23 16:26 | 3/6/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Turney Patricia A. | CA | O | SVP,Oper | S | -13 | 15.26 | 0 | -1 | -1 | 63 | D | | | | | | | | | | | | | | |
3/8/23 16:26 | 3/6/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Osborne David W | CA | O | Chief Te | S | -11 | 15.26 | 0 | -1 | 0 | 269 | D | | | | | | | | | | | | | | |
3/8/23 16:25 | 3/6/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Lock Kenneth A. | CA | O | Chief Co | S | -13 | 15.26 | 0 | -1 | -1 | 63 | D | | | | | | | | | | | | | | |
3/6/23 18:54 | 3/2/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Moore Matthew Richard | CA | O | See Rema | S.d | -25 | 15.83 | 0 | -2 | -6 | 27 | D | | | | | | | | | | | | | | |
3/6/23 18:52 | 3/2/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Matsuda Masaru | CA | O | See Rema | S.d | -23 | 15.83 | 0 | -1 | -4 | 39 | D | | | | | | | | | | | | | | |
3/6/23 18:51 | 3/2/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Burnett Patrick | CA | O | See Rema | S.d | -28 | 15.83 | 0 | -2 | -3 | 61 | D | | | | | | | | | | | | | | |
3/2/23 19:07 | 2/28/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Turney Patricia A. | CA | O | SVP,Oper | S.m | -38 | 15.96 | 0 | -2 | -5 | 46 | D | | | | | | | | | | | | | | |
3/2/23 19:06 | 2/28/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S.m | -124 | 15.93 | 0 | -8 | -1 | 587 | D | | | | | | | | | | | | | | |
3/2/23 19:05 | 2/28/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | CA | O | CFO | S.m | -29 | 15.90 | 0 | -2 | -5 | 38 | D | | | | | | | | | | | | | | |
3/2/23 19:04 | 2/28/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Lock Kenneth A. | CA | O | Chief Co | S.m | -38 | 15.96 | 0 | -2 | -5 | 43 | D | | | | | | | | | | | | | | |
3/2/23 19:03 | 2/28/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Osborne David W | CA | O | Chief Te | S.m | -32 | 15.96 | 0 | -2 | -1 | 255 | D | | | | | | | | | | | | | | |
2/21/23 07:20 | 2/15/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 14 | 1.68 | 0 | 9 | 5 | 191 | D | | | | | | | | | | | | | | |
2/21/23 07:20 | 2/15/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | S.d | -144 | 16.98 | 0 | -9 | -4 | 191 | D | | | | | | | | | | | | | | |
2/15/23 19:09 | 2/13/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S.m | -17 | 17.01 | 0 | -1 | 0 | 595 | D | | | | | | | | | | | | | | |
2/3/23 16:26 | 2/1/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S | -17 | 17.00 | 0 | -1 | 0 | 596 | D | | | | | | | | | | | | | | |
1/18/23 20:18 | 1/17/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 14 | 1.68 | 0 | 9 | 5 | 191 | D | | | | | | | | | | | | | | |
1/18/23 20:18 | 1/17/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | S.d | -117 | 13.72 | 0 | -9 | -4 | 191 | D | | | | | | | | | | | | | | |
1/4/23 17:15 | 1/3/23 | ARQT | Health | Drug | Pharmaceutical Preparations | Burnett Patrick | CA | O | See Rema | S | -22 | 15.01 | 0 | -1 | -3 | 42 | D | | | | | | | | | | | | | | |
12/9/22 16:47 | 12/7/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S | -17 | 17.06 | 0 | -1 | 0 | 597 | D | | | | | | | | | | | | | | |
11/22/22 19:06 | 11/21/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Matsuda Masaru | CA | O | See Rema | S | -31 | 18.19 | 0 | -2 | -8 | 20 | D | | | | | | | | | | | | | | |
11/17/22 16:29 | 11/15/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 2 | 1.68 | 0 | 1 | 1 | 191 | D | | | | | | | | | | | | | | |
11/17/22 16:29 | 11/15/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | S.d | -68 | 20.01 | 0 | -3 | -2 | 191 | D | | | | | | | | | | | | | | |
11/9/22 16:39 | 11/7/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | See Rema | S | -18 | 18.00 | 0 | -1 | 0 | 598 | D | | | | | | | | | | | | | | |
10/11/22 18:47 | 10/7/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -20 | 19.51 | 0 | -1 | 0 | 599 | D | | | | | | | | | | | | | | |
10/6/22 16:26 | 10/4/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | S | -122 | 20.29 | 0 | -6 | -3 | 193 | D | | | | | | | | | | | | | | |
9/20/22 16:37 | 9/16/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | CA | O | CFO | M.d | 8 | 1.68 | 0 | 5 | 14 | 40 | D | | | | | | | | | | | | | | |
9/9/22 17:10 | 9/7/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -22 | 21.51 | 0 | -1 | 0 | 600 | D | | | | | | | | | | | | | | |
8/17/22 17:06 | 8/15/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | S | -149 | 24.80 | 0 | -6 | -3 | 199 | D | | | | | | | | | | | | | | |
8/4/22 20:42 | 3/23/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Turney Patricia A. | CA | O | SVP,Oper | M.ad | 100 | 6.52 | 0 | 15 | 49 | 46 | D | | | | | | | | | | | | | | |
7/18/22 18:53 | 7/18/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | S | -146 | 24.40 | 0 | -6 | -3 | 205 | D | | | | | | | | | | | | | | |
7/12/22 19:30 | 7/8/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Osborne David W | CA | O | Chief Te | S | -56 | 25.41 | 0 | -2 | -1 | 257 | D | | | | | | | | | | | | | | |
7/12/22 19:30 | 7/8/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -342 | 25.37 | 0 | -14 | -2 | 870 | D | | | | | | | | | | | | | | |
7/12/22 19:30 | 7/8/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 12 | 1.68 | 0 | 7 | 1 | 870 | D | | | | | | | | | | | | | | |
7/7/22 16:04 | 7/6/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -22 | 22.07 | 0 | -1 | 0 | 876 | D | | | | | | | | | | | | | | |
6/28/22 16:29 | 6/24/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Orbimed Advisors LLC | NY | T | | S | -7,287 | 21.31 | 0 | -342 | -45 | 415 | I | | | | | | | | | | | | | | |
6/6/22 16:06 | 6/6/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -21 | 21.06 | 0 | -1 | 0 | 877 | D | | | | | | | | | | | | | | |
6/2/22 16:48 | 6/2/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Matsuda Masaru | CA | O | SVP,GC | S | -35 | 19.73 | 0 | -2 | -10 | 16 | D | | | | | | | | | | | | | | |
6/2/22 16:48 | 6/1/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 4 | 1.68 | 0 | 3 | 1 | 207 | D | | | | | | | | | | | | | | |
6/2/22 16:48 | 6/1/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | S.d | -52 | 20.62 | 0 | -3 | -1 | 207 | D | | | | | | | | | | | | | | |
5/5/22 17:31 | 5/5/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -22 | 21.76 | 0 | -1 | 0 | 877 | D | | | | | | | | | | | | | | |
5/3/22 17:14 | 5/2/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 3 | 1.02 | 0 | 3 | 1 | 207 | D | | | | | | | | | | | | | | |
5/3/22 17:14 | 5/2/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | S.d | -51 | 20.44 | 0 | -3 | -1 | 207 | D | | | | | | | | | | | | | | |
4/21/22 18:32 | 4/21/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Osborne David W | CA | O | Chief Te | S | -45 | 20.42 | 0 | -2 | -1 | 257 | D | | | | | | | | | | | | | | |
4/8/22 18:06 | 4/6/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Orbimed Advisors LLC | NY | T | | S.m | -18,164 | 20.68 | 0 | -878 | -66 | 451 | I | | | | | | | | | | | | | | |
4/5/22 18:45 | 4/5/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -21 | 21.43 | 0 | -1 | 0 | 878 | D | | | | | | | | | | | | | | |
4/1/22 16:55 | 4/1/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 4 | 0.5802 | 0 | 8 | 4 | 207 | D | | | | | | | | | | | | | | |
4/1/22 16:55 | 4/1/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | S.d | -150 | 20.02 | 0 | -8 | -3 | 207 | D | | | | | | | | | | | | | | |
3/30/22 20:02 | 3/23/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Turney Patricia A. | CA | O | SVP,Oper | M.ad | 165 | 6.52 | 0 | 25 | 81 | 56 | D | | | | | | | | | | | | | | |
3/11/22 21:42 | 3/9/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -5 | 17.00 | 0 | 0 | 0 | 879 | D | | | | | | | | | | | | | | |
3/7/22 20:59 | 3/4/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.dm | -55 | 16.90 | 0 | -3 | 0 | 879 | D | | | | | | | | | | | | | | |
3/7/22 20:59 | 3/7/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 1 | 1.68 | 0 | 1 | 0 | 879 | D | | | | | | | | | | | | | | |
3/7/22 20:53 | 3/4/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Burnett Patrick | CA | O | See Rema | S.dm | -17 | 16.85 | 0 | -1 | -2 | 43 | D | | | | | | | | | | | | | | |
3/7/22 20:49 | 3/4/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Lock Kenneth A. | CA | O | Chief Co | S.dm | -17 | 16.85 | 0 | -1 | -2 | 44 | D | | | | | | | | | | | | | | |
3/7/22 20:49 | 3/4/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | CA | O | CFO | S.dm | -5 | 16.85 | 0 | 0 | -1 | 35 | D | | | | | | | | | | | | | | |
3/7/22 20:48 | 3/4/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Turney Patricia A. | CA | O | SVP,Oper | S.dm | -17 | 16.85 | 0 | -1 | -3 | 31 | D | | | | | | | | | | | | | | |
3/7/22 20:47 | 3/4/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Osborne David W | CA | O | Chief Te | S.dm | -14 | 16.85 | 0 | -1 | 0 | 259 | D | | | | | | | | | | | | | | |
3/3/22 16:18 | 3/1/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -38 | 17.75 | 0 | -2 | 0 | 811 | D | | | | | | | | | | | | | | |
3/3/22 16:18 | 3/1/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Osborne David W | CA | O | Chief Te | S | -14 | 17.75 | 0 | -1 | 0 | 247 | D | | | | | | | | | | | | | | |
3/3/22 16:17 | 3/1/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | CA | O | CFO | S | -7 | 17.75 | 0 | 0 | -2 | 22 | D | | | | | | | | | | | | | | |
3/3/22 16:16 | 3/1/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Turney Patricia A. | CA | O | SVP,Oper | S | -17 | 17.75 | 0 | -1 | -5 | 19 | D | | | | | | | | | | | | | | |
3/3/22 16:15 | 3/1/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Lock Kenneth A. | CA | O | Chief Co | S | -17 | 17.75 | 0 | -1 | -3 | 32 | D | | | | | | | | | | | | | | |
2/11/22 17:55 | 2/9/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 2 | 1.68 | 0 | 1 | 0 | 813 | D | | | | | | | | | | | | | | |
2/11/22 17:55 | 2/9/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -17 | 17.00 | 0 | -1 | 0 | 813 | D | | | | | | | | | | | | | | |
1/7/22 16:17 | 1/5/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 2 | 1.68 | 0 | 1 | 0 | 813 | D | | | | | | | | | | | | | | |
1/7/22 16:17 | 1/5/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -22 | 21.59 | 0 | -1 | 0 | 813 | D | | | | | | | | | | | | | | |
1/5/22 17:19 | 1/3/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 1 | 0.5802 | 0 | 3 | 1 | 207 | D | | | | | | | | | | | | | | |
1/5/22 17:19 | 1/3/22 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | S.d | -53 | 21.21 | 0 | -3 | -1 | 207 | D | | | | | | | | | | | | | | |
12/28/21 17:00 | 12/27/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Burrows Scott L | CA | O | CFO | S | -252 | 20.07 | 0 | -13 | -36 | 23 | D | | | | | | | | | | | | | | |
12/23/21 21:46 | 12/23/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 1 | 0.5802 | 0 | 3 | 1 | 207 | D | | | | | | | | | | | | | | |
12/23/21 21:46 | 12/23/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | S.d | -50 | 20.16 | 0 | -3 | -1 | 207 | D | | | | | | | | | | | | | | |
12/10/21 18:41 | 12/8/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 2 | 1.68 | 0 | 1 | 0 | 813 | D | | | | | | | | | | | | | | |
12/10/21 18:41 | 12/8/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -17 | 17.00 | 0 | -1 | 0 | 813 | D | | | | | | | | | | | | | | |
11/9/21 17:19 | 11/5/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 2 | 1.68 | 0 | 1 | 0 | 813 | D | | | | | | | | | | | | | | |
11/9/21 17:19 | 11/5/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -22 | 21.50 | 0 | -1 | 0 | 813 | D | | | | | | | | | | | | | | |
11/3/21 17:16 | 11/1/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 1 | 0.5802 | 0 | 3 | 1 | 207 | D | | | | | | | | | | | | | | |
11/3/21 17:16 | 11/1/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | S.d | -55 | 21.81 | 0 | -3 | -1 | 207 | D | | | | | | | | | | | | | | |
10/7/21 16:05 | 10/5/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 4 | 1.68 | 0 | 3 | 0 | 813 | D | | | | | | | | | | | | | | |
10/7/21 16:05 | 10/5/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -62 | 24.92 | 0 | -3 | 0 | 813 | D | | | | | | | | | | | | | | |
10/5/21 14:11 | 10/1/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 1 | 0.5802 | 0 | 3 | 1 | 207 | D | | | | | | | | | | | | | | |
10/5/21 14:11 | 10/1/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | S.d | -60 | 23.87 | 0 | -3 | -1 | 207 | D | | | | | | | | | | | | | | |
10/5/21 14:10 | 10/1/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 3 | 1.68 | 0 | 2 | 0 | 813 | D | | | | | | | | | | | | | | |
10/5/21 14:10 | 10/1/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -38 | 25.01 | 0 | -2 | 0 | 813 | D | | | | | | | | | | | | | | |
9/9/21 17:42 | 9/7/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 2 | 1.68 | 0 | 1 | 0 | 813 | D | | | | | | | | | | | | | | |
9/9/21 17:42 | 9/7/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -21 | 21.14 | 0 | -1 | 0 | 813 | D | | | | | | | | | | | | | | |
9/3/21 17:07 | 9/1/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 8 | 1.56 | 0 | 5 | 2 | 207 | D | | | | | | | | | | | | | | |
9/3/21 17:07 | 9/1/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | S.d | -104 | 20.80 | 0 | -5 | -2 | 207 | D | | | | | | | | | | | | | | |
8/9/21 18:51 | 8/5/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 2 | 1.68 | 0 | 1 | 0 | 813 | D | | | | | | | | | | | | | | |
8/9/21 18:51 | 8/5/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -21 | 20.81 | 0 | -1 | 0 | 813 | D | | | | | | | | | | | | | | |
7/8/21 19:40 | 7/6/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 3 | 1.68 | 0 | 2 | 0 | 813 | D | | | | | | | | | | | | | | |
7/8/21 19:40 | 7/6/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -47 | 26.58 | 0 | -2 | 0 | 813 | D | | | | | | | | | | | | | | |
7/6/21 19:14 | 7/1/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 9 | 3.94 | 0 | 2 | 1 | 207 | D | | | | | | | | | | | | | | |
7/6/21 19:14 | 7/1/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | S.d | -57 | 26.13 | 0 | -2 | -1 | 207 | D | | | | | | | | | | | | | | |
6/28/21 16:11 | 6/24/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Chaudhuri Bhaskar | CA | D | | S.m | -206 | 27.50 | 0 | -7 | -1 | 891 | D | | | | | | | | | | | | | | |
6/23/21 17:47 | 6/21/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Chaudhuri Bhaskar | CA | D | | S | -69 | 27.50 | 0 | -3 | 0 | 899 | D | | | | | | | | | | | | | | |
6/9/21 16:35 | 6/7/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 3 | 1.68 | 0 | 2 | 0 | 805 | D | | | | | | | | | | | | | | |
6/9/21 16:35 | 6/7/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -46 | 26.35 | 0 | -2 | 0 | 805 | D | | | | | | | | | | | | | | |
6/3/21 16:39 | 6/1/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Chaudhuri Bhaskar | CA | D | | S | -275 | 27.50 | 0 | -10 | -1 | 901 | D | | | | | | | | | | | | | | |
6/3/21 16:37 | 6/1/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 9 | 3.95 | 0 | 2 | 1 | 238 | D | | | | | | | | | | | | | | |
6/3/21 16:37 | 6/1/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | S.d | -60 | 27.09 | 0 | -2 | -1 | 238 | D | | | | | | | | | | | | | | |
5/25/21 15:10 | 5/21/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 1 | 0.8464 | 0 | 2 | 1 | 238 | D | | | | | | | | | | | | | | |
5/19/21 18:43 | 4/20/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Chaudhuri Bhaskar | CA | D | | S.a | -281 | 28.06 | 0 | -10 | -1 | 911 | D | | | | | | | | | | | | | | |
5/11/21 11:47 | 5/7/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 1 | 1.68 | 0 | 1 | 0 | 804 | D | | | | | | | | | | | | | | |
5/11/21 11:47 | 5/7/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -26 | 35.00 | 0 | -1 | 0 | 804 | D | | | | | | | | | | | | | | |
5/7/21 11:29 | 5/5/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 3 | 1.68 | 0 | 2 | 0 | 804 | D | | | | | | | | | | | | | | |
5/7/21 11:29 | 5/5/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -60 | 34.00 | 0 | -2 | 0 | 804 | D | | | | | | | | | | | | | | |
5/5/21 14:05 | 5/3/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 9 | 3.94 | 0 | 2 | 1 | 236 | D | | | | | | | | | | | | | | |
5/5/21 14:05 | 5/3/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | S.d | -77 | 34.79 | 0 | -2 | -1 | 236 | D | | | | | | | | | | | | | | |
5/4/21 15:00 | 4/30/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -53 | 35.00 | 0 | -2 | 0 | 805 | D | | | | | | | | | | | | | | |
4/22/21 20:17 | 4/20/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Chaudhuri Bhaskar | CA | D | | S | -281 | 28.06 | 0 | -10 | -1 | 911 | D | | | | | | | | | | | | | | |
4/20/21 17:43 | 4/16/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 3 | 1.17 | 0 | 3 | 1 | 236 | D | | | | | | | | | | | | | | |
4/6/21 17:30 | 4/5/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -52 | 29.93 | 0 | -2 | 0 | 806 | D | | | | | | | | | | | | | | |
4/5/21 17:33 | 4/1/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 9 | 3.95 | 0 | 2 | 1 | 233 | D | | | | | | | | | | | | | | |
4/5/21 17:33 | 4/1/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | S.d | -65 | 29.49 | 0 | -2 | -1 | 233 | D | | | | | | | | | | | | | | |
3/24/21 11:33 | 3/22/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Chaudhuri Bhaskar | CA | D | | S | -311 | 31.10 | 0 | -10 | -1 | 921 | D | | | | | | | | | | | | | | |
3/18/21 13:59 | 3/16/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 3 | 1.17 | 0 | 3 | 1 | 233 | D | | | | | | | | | | | | | | |
3/11/21 15:59 | 3/10/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Smither John W | CA | O | CFO | M.d | 1 | 1.68 | 0 | 1 | 0 | 133 | M | | | | | | | | | | | | | | |
3/11/21 15:59 | 3/10/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Smither John W | CA | O | CFO | S.d | -58 | 32.90 | 0 | -2 | -1 | 133 | M | | | | | | | | | | | | | | |
3/5/21 15:56 | 3/5/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -53 | 30.55 | 0 | -2 | 0 | 808 | D | | | | | | | | | | | | | | |
3/5/21 15:55 | 3/4/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Smither John W | CA | O | CFO | M.d | 21 | 1.68 | 0 | 12 | 10 | 134 | D | | | | | | | | | | | | | | |
3/3/21 16:51 | 3/2/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S | -74 | 35.19 | 0 | -2 | 0 | 777 | D | | | | | | | | | | | | | | |
3/3/21 16:50 | 3/1/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Osborne David W | CA | O | Chief Te | S | -27 | 34.57 | 0 | -1 | 0 | 237 | D | | | | | | | | | | | | | | |
3/3/21 16:49 | 3/1/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Turney Patricia A. | CA | O | SVP,Oper | S | -32 | 34.52 | 0 | -1 | -9 | 9 | D | | | | | | | | | | | | | | |
3/3/21 16:48 | 3/1/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Smither John W | CA | O | CFO | S | -26 | 34.20 | 0 | -1 | -1 | 112 | D | | | | | | | | | | | | | | |
3/3/21 16:47 | 3/1/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Lock Kenneth A. | CA | O | Chief Co | S | -32 | 34.20 | 0 | -1 | -4 | 22 | D | | | | | | | | | | | | | | |
3/3/21 16:45 | 3/1/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 9 | 3.92 | 0 | 2 | 1 | 231 | D | | | | | | | | | | | | | | |
3/3/21 16:45 | 3/1/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | S.d | -76 | 34.37 | 0 | -2 | -1 | 231 | D | | | | | | | | | | | | | | |
2/24/21 15:33 | 2/22/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Chaudhuri Bhaskar | CA | D | | S | -355 | 35.52 | 0 | -10 | -1 | 931 | D | | | | | | | | | | | | | | |
2/17/21 20:35 | 2/16/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 3 | 1.17 | 0 | 3 | 1 | 231 | D | | | | | | | | | | | | | | |
2/12/21 17:32 | 2/10/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Smither John W | CA | O | CFO | M.d | 1 | 1.68 | 0 | 1 | 1 | 113 | M | | | | | | | | | | | | | | |
2/12/21 17:32 | 2/10/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Smither John W | CA | O | CFO | S.d | -98 | 35.64 | 0 | -3 | -2 | 113 | M | | | | | | | | | | | | | | |
2/8/21 16:00 | 2/5/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 17 | 1.68 | 0 | 10 | 1 | 779 | D | | | | | | | | | | | | | | |
2/8/21 16:00 | 2/5/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -343 | 34.29 | 0 | -10 | -1 | 779 | D | | | | | | | | | | | | | | |
2/8/21 13:45 | 2/4/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 33 | 1.68 | 0 | 20 | 10 | 228 | D | | | | | | | | | | | | | | |
2/3/21 11:24 | 2/1/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 4 | 1.68 | 0 | 2 | 1 | 208 | D | | | | | | | | | | | | | | |
2/3/21 11:24 | 2/1/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | S.d | -76 | 34.35 | 0 | -2 | -1 | 208 | D | | | | | | | | | | | | | | |
2/3/21 11:23 | 2/1/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Smither John W | CA | O | CFO | M.d | 2 | 1.68 | 0 | 1 | 1 | 115 | M | | | | | | | | | | | | | | |
2/3/21 11:23 | 2/1/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Smither John W | CA | O | CFO | S.d | -175 | 35.00 | 0 | -5 | -4 | 115 | M | | | | | | | | | | | | | | |
2/2/21 19:39 | 1/29/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Chaudhuri Bhaskar | CA | D | | S.m | -332 | 33.22 | 0 | -10 | -1 | 941 | D | | | | | | | | | | | | | | |
1/21/21 16:41 | 1/19/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Smither John W | CA | O | CFO | M.d | 1 | 1.68 | 0 | 1 | 0 | 119 | M | | | | | | | | | | | | | | |
1/21/21 16:41 | 1/19/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Smither John W | CA | O | CFO | S.d | -53 | 30.00 | 0 | -2 | -1 | 119 | M | | | | | | | | | | | | | | |
1/14/21 11:11 | 1/12/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 1 | 0.5802 | 0 | 1 | 1 | 208 | D | | | | | | | | | | | | | | |
1/7/21 15:13 | 1/5/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.ad | 17 | 1.68 | 0 | 10 | 1 | 779 | D | | | | | | | | | | | | | | |
1/7/21 15:13 | 1/5/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.ad | -281 | 28.08 | 0 | -10 | -1 | 779 | D | | | | | | | | | | | | | | |
1/7/21 14:39 | 9/29/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 5 | 1.68 | 0 | 3 | 0 | 778 | D | | | | | | | | | | | | | | |
1/7/21 14:39 | 9/29/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -90 | 30.00 | 0 | -3 | 0 | 778 | D | | | | | | | | | | | | | | |
1/6/21 13:16 | 1/4/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 4 | 1.68 | 0 | 2 | 1 | 207 | D | | | | | | | | | | | | | | |
1/6/21 13:16 | 1/4/21 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | S.d | -61 | 27.82 | 0 | -2 | -1 | 207 | D | | | | | | | | | | | | | | |
12/16/20 15:15 | 12/14/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Osborne David W | CA | O | Chief Te | S | -450 | 30.00 | 0 | -15 | -4 | 375 | D | | | | | | | | | | | | | | |
12/16/20 15:14 | 12/14/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Smither John W | CA | O | CFO | M.d | 3 | 1.68 | 0 | 2 | 1 | 120 | M | | | | | | | | | | | | | | |
12/16/20 15:14 | 12/14/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Smither John W | CA | O | CFO | S.d | -158 | 30.00 | 0 | -5 | -4 | 120 | M | | | | | | | | | | | | | | |
12/16/20 15:14 | 12/14/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 1 | 0.5802 | 0 | 1 | 1 | 207 | D | | | | | | | | | | | | | | |
12/3/20 19:40 | 12/1/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 4 | 1.68 | 0 | 2 | 1 | 205 | D | | | | | | | | | | | | | | |
12/3/20 19:40 | 12/1/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | S.d | -57 | 25.98 | 0 | -2 | -1 | 205 | D | | | | | | | | | | | | | | |
11/13/20 11:57 | 11/12/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 1 | 0.5802 | 0 | 1 | 1 | 205 | D | | | | | | | | | | | | | | |
11/4/20 16:33 | 11/2/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 4 | 1.68 | 0 | 2 | 1 | 204 | D | | | | | | | | | | | | | | |
11/4/20 16:33 | 11/2/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | S.d | -40 | 18.27 | 0 | -2 | -1 | 204 | D | | | | | | | | | | | | | | |
10/27/20 14:03 | 10/26/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Lock Kenneth A. | CA | O | Chief Co | M.d | 17 | 6.52 | 0 | 3 | 14 | 22 | D | | | | | | | | | | | | | | |
10/23/20 13:27 | 10/22/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Lock Kenneth A. | CA | O | Chief Co | M.d | 18 | 6.52 | 0 | 3 | 16 | 19 | D | | | | | | | | | | | | | | |
10/16/20 14:06 | 10/15/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Lock Kenneth A. | CA | O | Chief Co | M.d | 49 | 6.52 | 0 | 8 | 83 | 17 | D | | | | | | | | | | | | | | |
10/16/20 14:06 | 10/15/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 1 | 0.5802 | 0 | 1 | 1 | 204 | D | | | | | | | | | | | | | | |
10/6/20 17:27 | 10/2/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Orbimed Advisors LLC | NY | DT | | P | 12,400 | 25.00 | 0 | 496 | 122 | 902 | I | | | | | | | | | | | | | | |
10/6/20 17:23 | 10/2/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Silverstein Jonathan | CA | DT | | P | 12,400 | 25.00 | 0 | 496 | 122 | 902 | I | | | | | | | | | | | | | | |
10/5/20 21:13 | 10/1/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 4 | 1.68 | 0 | 2 | 1 | 202 | D | | | | | | | | | | | | | | |
10/5/20 21:13 | 10/1/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | S.d | -61 | 27.65 | 0 | -2 | -1 | 202 | D | | | | | | | | | | | | | | |
10/5/20 21:12 | 9/1/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.ad | 4 | 1.68 | 0 | 2 | 1 | 201 | D | | | | | | | | | | | | | | |
10/5/20 21:12 | 9/1/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | S.ad | -54 | 24.38 | 0 | -2 | -1 | 201 | D | | | | | | | | | | | | | | |
10/1/20 21:02 | 9/29/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | M.d | 5 | 1.68 | 0 | 3 | 0 | 778 | D | | | | | | | | | | | | | | |
10/1/20 21:02 | 9/29/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Watanabe Todd Franklin | CA | DO | P,CEO | S.d | -90 | 30.00 | 0 | -3 | 0 | 778 | D | | | | | | | | | | | | | | |
10/1/20 21:01 | 9/29/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Osborne David W | CA | O | Chief Te | S | -450 | 30.00 | 0 | -15 | -4 | 389 | D | | | | | | | | | | | | | | |
10/1/20 21:00 | 9/29/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Smither John W | CA | O | CFO | M.d | 1 | 1.68 | 0 | 1 | 0 | 123 | M | | | | | | | | | | | | | | |
10/1/20 21:00 | 9/29/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Smither John W | CA | O | CFO | S.d | -53 | 30.00 | 0 | -2 | -1 | 123 | M | | | | | | | | | | | | | | |
9/16/20 17:57 | 9/15/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 1 | 0.5802 | 0 | 1 | 1 | 202 | D | | | | | | | | | | | | | | |
9/2/20 11:48 | 9/1/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 4 | 1.68 | 0 | 2 | 1 | 201 | D | | | | | | | | | | | | | | |
9/2/20 11:48 | 9/1/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | S.d | -54 | 24.38 | 0 | -2 | -1 | 201 | D | | | | | | | | | | | | | | |
8/21/20 14:19 | 8/20/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 8 | 1.68 | 0 | 5 | 3 | 201 | D | | | | | | | | | | | | | | |
8/19/20 17:48 | 8/18/20 | ARQT | Health | Drug | Pharmaceutical Preparations | Welgus Howard G. | CA | D | | M.d | 9 | 1.68 | 0 | 5 | 3 | 196 | D | | | | | | | | | | | | | | |